SITUS JUDI MBL77 - AN OVERVIEW

Not all patients with CLL call for therapy. Even with all the latest improvements, the iwCLL continue to recommends watchful observation for people with asymptomatic disorder.86 This suggestion is based on a minimum of two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FC